Howard Capital Management’s Merck MRK Stock Holding History

Howard Capital Management’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.39M	Buy	18,609 +7,275	+64%	+$852K	0.03%	166
2026 Q1	$1.36M	Sell	11,334 -20,510	-64%	-$2.37M	0.02%	153
2025 Q4	$3.35M	Buy	31,844 +5,441	+21%	+$511K	0.04%	129
2025 Q3	$2.22M	Buy	26,403 +1,712	+7%	+$141K	0.03%	153
2025 Q2	$1.97M	Buy	24,691 +9,779	+66%	+$777K	0.03%	156
2025 Q1	$1.34M	Sell	14,912 -2,281	-13%	-$213K	0.03%	165
2024 Q4	$1.71M	Buy	17,193 +858	+5%	+$88.5K	0.03%	162
2024 Q3	$1.86M	Buy	+16,335	New	+$1.94M	0.03%	147
2023 Q1	–	Sell	-2,759	Closed	-$308K	–	50
2022 Q4	$308K	Buy	+2,759	New	+$282K	0.09%	24
2022 Q3	–	Sell	-2,866	Closed	-$263K	–	29
2022 Q2	$263K	Buy	+2,866	New	+$254K	0.07%	29
2018 Q4	–	Sell	-184,386	Closed	-$12.5M	–	45
2018 Q3	$12.5M	Sell	184,386 -69	-0%	-$4.4K	1.2%	20
2018 Q2	$11M	Buy	+184,455	New	+$10.4M	1.21%	21

Other funds holding MRK

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Howard Capital Management's MRK Position: Q2 2026 in Review

Howard Capital Management increased its Merck (MRK) stake by 64% in Q2 2026, buying an estimated $852K and bringing the position to 18,609 shares worth $2.39M. The position accounts for 0.03% of the portfolio, ranked #166.

Howard Capital Management first reported a position in MRK in Q2 2018 and has held it in 12 quarters since. The position peaked at $12.5M in Q3 2018. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

Howard Capital Management held 18,609 shares of Merck worth $2.39M as of Q2 2026.
Howard Capital Management bought 7,275 Merck shares in Q2 2026, an estimated $852K.
Merck made up 0.03% of Howard Capital Management's portfolio in Q2 2026, its #166 holding.
Howard Capital Management first reported a position in Merck in Q2 2018 and has held it in 12 quarters since.
Howard Capital Management's Merck position peaked at $12.5M in Q3 2018.
1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Howard Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.